Imagine spending $70,000 a year on a health regimen that includes 40 daily supplements and unproven peptides—all in the pursuit of peak performance. Is this the future of wellness, or a risky gamble? Marketing executive Andrew Raso thinks it’s the former. His day begins at dawn with a ritual of sunlight exposure, saltwater hydration, and a barefoot walk on grass—practices rooted in ancient traditions. But here’s where it gets controversial: he then consumes a cocktail of peptides, each promising everything from joint repair to better sleep and increased human growth hormone. The catch? None of these peptides are clinically proven to work in humans. Yet, Raso is undeterred, citing promising preclinical data (https://journals.lww.com/jaaosglobal/fulltext/2026/01000/therapeuticpeptidesinorthopaedics.1.aspx) and claiming they give him a competitive edge. For him, health isn’t just about avoiding illness—it’s about optimizing performance. He boldly declares he feels great 99% of the time, criticizing the societal norm of accepting daily fatigue. But is this extreme approach sustainable, or even necessary? And this is the part most people miss: could such regimens widen the gap between those who can afford experimental treatments and those who can’t? As we navigate the evolving landscape of health and wellness, Raso’s story raises thought-provoking questions. What do you think—is this the next frontier in self-care, or a step too far? Share your thoughts in the comments below. (Health and wellness reporter Euan Black explores these trends at The Australian Financial Review. Subscribe now to dive deeper: https://subscribe.afr.com/?promotechannel=HIAGFTGNLGIFTCTA&utmsource=ArticleGifting&utmmedium=HouseInventory&utmcampaign=General&utmcontent=GiftCTA)
